Liposomal Docetaxel clinical trials
A product of Docetaxel; its studies count on that page too.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2008
How each study uses Liposomal Docetaxel is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 14 May 1996 · TAXOTERE · NDA 020449 (FDA, Drugs@FDA; as Docetaxel)
- European Union
- 27 Nov 1995 · Taxotere · EMEA/H/C/000073 (EMA; as Docetaxel)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
3 studies that test it; most in 2010 (2)
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2010 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 0
Related medicines
As reviewed, each with the page that says it.
- A dosage form of Docetaxel
- One of Antimitotic agents source
Studies
Open first, then newest update. How each study uses Liposomal Docetaxel is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Efficacy and Safety Study of LE-DT to Treat Metastatic Castrate Resistant Prostate CancerWithdrawnPhase 2INSYS Therapeutics IncNCT01188408Written as Liposome Entrapped Docetaxel (LE-DT)How we know
- Efficacy and Safety Study of LE-DT to Treat Locally Advanced or Metastatic Pancreatic CancerCompletedPhase 2INSYS Therapeutics IncNCT01186731Written as Liposome Entrapped Docetaxel (LE-DT)How we know
- Liposome Encapsulated Docetaxel (LE-DT) in Patients With Solid TumorsCompletedPhase 1INSYS Therapeutics IncNCT01151384Written as LE-DTHow we know